Cargando…

Repetitive Neonatal Erythropoietin and Melatonin Combinatorial Treatment Provides Sustained Repair of Functional Deficits in a Rat Model of Cerebral Palsy

Cerebral palsy (CP) is the leading cause of motor impairment for children worldwide and results from perinatal brain injury (PBI). To test novel therapeutics to mitigate deficits from PBI, we developed a rat model of extreme preterm birth (<28 weeks of gestation) that mimics dual intrauterine inj...

Descripción completa

Detalles Bibliográficos
Autores principales: Jantzie, Lauren L., Oppong, Akosua Y., Conteh, Fatu S., Yellowhair, Tracylyn R., Kim, Joshua, Fink, Gabrielle, Wolin, Adam R., Northington, Frances J., Robinson, Shenandoah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908903/
https://www.ncbi.nlm.nih.gov/pubmed/29706928
http://dx.doi.org/10.3389/fneur.2018.00233
_version_ 1783315789300891648
author Jantzie, Lauren L.
Oppong, Akosua Y.
Conteh, Fatu S.
Yellowhair, Tracylyn R.
Kim, Joshua
Fink, Gabrielle
Wolin, Adam R.
Northington, Frances J.
Robinson, Shenandoah
author_facet Jantzie, Lauren L.
Oppong, Akosua Y.
Conteh, Fatu S.
Yellowhair, Tracylyn R.
Kim, Joshua
Fink, Gabrielle
Wolin, Adam R.
Northington, Frances J.
Robinson, Shenandoah
author_sort Jantzie, Lauren L.
collection PubMed
description Cerebral palsy (CP) is the leading cause of motor impairment for children worldwide and results from perinatal brain injury (PBI). To test novel therapeutics to mitigate deficits from PBI, we developed a rat model of extreme preterm birth (<28 weeks of gestation) that mimics dual intrauterine injury from placental underperfusion and chorioamnionitis. We hypothesized that a sustained postnatal treatment regimen that combines the endogenous neuroreparative agents erythropoietin (EPO) and melatonin (MLT) would mitigate molecular, sensorimotor, and cognitive abnormalities in adults rats following prenatal injury. On embryonic day 18 (E18), a laparotomy was performed in pregnant Sprague–Dawley rats. Uterine artery occlusion was performed for 60 min to induce placental insufficiency via transient systemic hypoxia-ischemia, followed by intra-amniotic injections of lipopolysaccharide, and laparotomy closure. On postnatal day 1 (P1), approximately equivalent to 30 weeks of gestation, injured rats were randomized to an extended EPO + MLT treatment regimen, or vehicle (sterile saline) from P1 to P10. Behavioral assays were performed along an extended developmental time course (n = 6–29). Open field testing shows injured rats exhibit hypermobility and disinhibition and that combined neonatal EPO + MLT treatment repairs disinhibition in injured rats, while EPO alone does not. Furthermore, EPO + MLT normalizes hindlimb deficits, including reduced paw area and paw pressure at peak stance, and elevated percent shared stance after prenatal injury. Injured rats had fewer social interactions than shams, and EPO + MLT normalized social drive. Touchscreen operant chamber testing of visual discrimination and reversal shows that EPO + MLT at least partially normalizes theses complex cognitive tasks. Together, these data indicate EPO + MLT can potentially repair multiple sensorimotor, cognitive, and behavioral realms following PBI, using highly translatable and sophisticated developmental testing platforms.
format Online
Article
Text
id pubmed-5908903
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-59089032018-04-27 Repetitive Neonatal Erythropoietin and Melatonin Combinatorial Treatment Provides Sustained Repair of Functional Deficits in a Rat Model of Cerebral Palsy Jantzie, Lauren L. Oppong, Akosua Y. Conteh, Fatu S. Yellowhair, Tracylyn R. Kim, Joshua Fink, Gabrielle Wolin, Adam R. Northington, Frances J. Robinson, Shenandoah Front Neurol Neuroscience Cerebral palsy (CP) is the leading cause of motor impairment for children worldwide and results from perinatal brain injury (PBI). To test novel therapeutics to mitigate deficits from PBI, we developed a rat model of extreme preterm birth (<28 weeks of gestation) that mimics dual intrauterine injury from placental underperfusion and chorioamnionitis. We hypothesized that a sustained postnatal treatment regimen that combines the endogenous neuroreparative agents erythropoietin (EPO) and melatonin (MLT) would mitigate molecular, sensorimotor, and cognitive abnormalities in adults rats following prenatal injury. On embryonic day 18 (E18), a laparotomy was performed in pregnant Sprague–Dawley rats. Uterine artery occlusion was performed for 60 min to induce placental insufficiency via transient systemic hypoxia-ischemia, followed by intra-amniotic injections of lipopolysaccharide, and laparotomy closure. On postnatal day 1 (P1), approximately equivalent to 30 weeks of gestation, injured rats were randomized to an extended EPO + MLT treatment regimen, or vehicle (sterile saline) from P1 to P10. Behavioral assays were performed along an extended developmental time course (n = 6–29). Open field testing shows injured rats exhibit hypermobility and disinhibition and that combined neonatal EPO + MLT treatment repairs disinhibition in injured rats, while EPO alone does not. Furthermore, EPO + MLT normalizes hindlimb deficits, including reduced paw area and paw pressure at peak stance, and elevated percent shared stance after prenatal injury. Injured rats had fewer social interactions than shams, and EPO + MLT normalized social drive. Touchscreen operant chamber testing of visual discrimination and reversal shows that EPO + MLT at least partially normalizes theses complex cognitive tasks. Together, these data indicate EPO + MLT can potentially repair multiple sensorimotor, cognitive, and behavioral realms following PBI, using highly translatable and sophisticated developmental testing platforms. Frontiers Media S.A. 2018-04-13 /pmc/articles/PMC5908903/ /pubmed/29706928 http://dx.doi.org/10.3389/fneur.2018.00233 Text en Copyright © 2018 Jantzie, Oppong, Conteh, Yellowhair, Kim, Fink, Wolin, Northington and Robinson. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Jantzie, Lauren L.
Oppong, Akosua Y.
Conteh, Fatu S.
Yellowhair, Tracylyn R.
Kim, Joshua
Fink, Gabrielle
Wolin, Adam R.
Northington, Frances J.
Robinson, Shenandoah
Repetitive Neonatal Erythropoietin and Melatonin Combinatorial Treatment Provides Sustained Repair of Functional Deficits in a Rat Model of Cerebral Palsy
title Repetitive Neonatal Erythropoietin and Melatonin Combinatorial Treatment Provides Sustained Repair of Functional Deficits in a Rat Model of Cerebral Palsy
title_full Repetitive Neonatal Erythropoietin and Melatonin Combinatorial Treatment Provides Sustained Repair of Functional Deficits in a Rat Model of Cerebral Palsy
title_fullStr Repetitive Neonatal Erythropoietin and Melatonin Combinatorial Treatment Provides Sustained Repair of Functional Deficits in a Rat Model of Cerebral Palsy
title_full_unstemmed Repetitive Neonatal Erythropoietin and Melatonin Combinatorial Treatment Provides Sustained Repair of Functional Deficits in a Rat Model of Cerebral Palsy
title_short Repetitive Neonatal Erythropoietin and Melatonin Combinatorial Treatment Provides Sustained Repair of Functional Deficits in a Rat Model of Cerebral Palsy
title_sort repetitive neonatal erythropoietin and melatonin combinatorial treatment provides sustained repair of functional deficits in a rat model of cerebral palsy
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908903/
https://www.ncbi.nlm.nih.gov/pubmed/29706928
http://dx.doi.org/10.3389/fneur.2018.00233
work_keys_str_mv AT jantzielaurenl repetitiveneonatalerythropoietinandmelatonincombinatorialtreatmentprovidessustainedrepairoffunctionaldeficitsinaratmodelofcerebralpalsy
AT oppongakosuay repetitiveneonatalerythropoietinandmelatonincombinatorialtreatmentprovidessustainedrepairoffunctionaldeficitsinaratmodelofcerebralpalsy
AT contehfatus repetitiveneonatalerythropoietinandmelatonincombinatorialtreatmentprovidessustainedrepairoffunctionaldeficitsinaratmodelofcerebralpalsy
AT yellowhairtracylynr repetitiveneonatalerythropoietinandmelatonincombinatorialtreatmentprovidessustainedrepairoffunctionaldeficitsinaratmodelofcerebralpalsy
AT kimjoshua repetitiveneonatalerythropoietinandmelatonincombinatorialtreatmentprovidessustainedrepairoffunctionaldeficitsinaratmodelofcerebralpalsy
AT finkgabrielle repetitiveneonatalerythropoietinandmelatonincombinatorialtreatmentprovidessustainedrepairoffunctionaldeficitsinaratmodelofcerebralpalsy
AT wolinadamr repetitiveneonatalerythropoietinandmelatonincombinatorialtreatmentprovidessustainedrepairoffunctionaldeficitsinaratmodelofcerebralpalsy
AT northingtonfrancesj repetitiveneonatalerythropoietinandmelatonincombinatorialtreatmentprovidessustainedrepairoffunctionaldeficitsinaratmodelofcerebralpalsy
AT robinsonshenandoah repetitiveneonatalerythropoietinandmelatonincombinatorialtreatmentprovidessustainedrepairoffunctionaldeficitsinaratmodelofcerebralpalsy